FDA approves Trevena’s Olinvyk for clinical controlled settings Aug. 10, 2020 By Lee Landenberger No Comments Knocked back by a complete response letter (CRL) in late 2018, Trevena Inc. dusted itself off, resubmitted its NDA for oliceridine and found satisfaction as the FDA has approved the opioid agonist.Read More